compound version of tirzepatide Compounded (GLP-1/GIP) Compounded Tirzepatide
Description
Please Note: If a patient experiences any gastrointestinal symptoms after using Wegovy to normalise blood sugar levels or reduce excess body weight, a healthcare provider should be informed as soon as possible
As a result, certain Athlete Support Personnel whose periods of ineligibility have expired in between these updates may remain on the Prohibited Association List until the next update
Additional information Supplementary information is available for this paper at XXXX
There was no increased rate of adverse effects leading to discontinuation of treatment in GLP-1RA users compared with nonGLP-1RA users (112)
What Was Approved
Understanding how to responsibly navigate this landscape is crucial for both scientific integrity and potential future innovation
